Through collaboration with CISCRP, Boston Scientific successfully customized and localized over ten brochures for use in device trials, maintaining IRB approval and cultural sensitivity. The tailored materials were made available in more than five languages and tested with over 500 community members to ensure accessibility and comprehension. This initiative strengthened Boston Scientific's patient outreach, enhanced participant understanding, and demonstrated the value and adaptability of CISCRP's codeveloped, user-tested educational content for sponsor-specific needs.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.